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The fully developed lesion of Alzheimer's disease is a dense plaque composed of fibrillar amyloid β-proteins (Aβ) with a characteristic and
well-ordered β-sheet secondary structure. Because the incipient lesion most likely develops when these proteins are first induced to form β-sheet
structure, it is important to understand factors that induced Aβ to adopt this conformation. In this review, we describe the application of polarized
attenuated total internal reflection infrared FT-IR spectroscopy for characterizing the conformation, orientation, and rate of accumulation of Aβ on
lipid membranes. We also describe the application and yield of linked analysis, whereby multiple spectra are fit simultaneously with component
bands that are constrained to share common fitting parameters. Results have shown that membranes promote β-sheet formation under a variety of
circumstances that may be significant to the pathogenesis of Alzheimer's disease.
Published by Elsevier B.V.Contents
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This paper reviews experimental evidence suggesting that
oxidatively damaged phospholipids stimulate the formation of
amyloid fibrils. Numerous investigations have been conducted
into the physical properties of amyloid β-proteins (Aβ) in an
attempt to understand why they form fibrillar plaques in the
cortical brain tissue of persons with Alzheimer's disease (AD).
Although a multitude of factors have been shown to stimulate
folding, refolding, and even unfolding of these proteins under
various circumstances [1], the fundamental reason that dense
plaques of fibrillar amyloid proteins form in patients with AD
remains elusive.
The rationale for suggesting that oxidatively damaged
phospholipids stimulate the formation of amyloid fibrils
includes two general observations. One, oxidative stress has
been implicated frequently in the pathogenesis of AD [2–8].
Two, lipids exert a profound influence on the secondary
structure of Aβ, in many cases inducing β-sheet structure [9–
15]. A link between these observations is suggested when
considering that lipids in the human brain contain a variety of
polyunsaturated fatty acyl (PUFA) chains in relatively high
concentration [16], and that the olefinic groups in these lipids
are highly susceptible to reactions with reactive oxygen
species. A link is also suggested by the observation that
plasma levels of the lipophilic antioxidant α-tocopherol are
reduced in AD [17]. There is evidence that cholesterol
oxidation occurs in vivo and that the products of cholesterol
oxidation can promote Aβ fibril formation [18,19]. However,
cholesterol oxidation requires somewhat harsher conditions
than PUFA oxidation.
Experimental evidence for the role of oxidatively damaged
phospholipids in Aβ fibril formation consists primarily of in
vitro studies with polarized attenuated total internal reflection-
Fourier transform infrared (PATIR-FTIR) spectroscopy. Various
implementations of this technique are being used with
increasing frequency to study protein–lipid interactions. It is
especially powerful for polypeptides that form β-sheet structureFig. 1. Schematic of the Langmuir trough currently used for PATIR-FTIR spectrosc
position such that a polarized and focused infrared beam from an FTIR spectrometer m
configuration, the beam makes an angle of 60° with the surface normal and internally
exiting through the other 30° end-facet. A lipid monolayer is formed at the air–water
by a feed back loop involving a Wilhelmy wire [30] for pressure measurement and a
trough until the monolayer contacts the horizontally positioned crystal. Samples are i
monolayer. Components in the figure are not drawn to scale.because they exhibit a distinctive “splitting” of their amide I
absorption and there are means for precise calculation of the tilt
angle between a β-sheet and a lipid membrane [20]. Our
approach to PATIR-FTIR spectroscopy differs from similar-
sounding but much simpler approaches, and it yields quantita-
tive information about the rate of accumulation, the conforma-
tion, and the orientation of proteins as they interact with a fully
hydrated lipid monolayer in a Langmuir trough [21,22].
Therefore, we begin with a brief description of the instrumenta-
tion, analytical procedures, and applicable theory.
2. PATIR-FTIR Spectroscopy
2.1. Instrumentation
The key innovation in the instrumentation used for PATIR-
FTIR is the manner in which internal reflection techniques are
used to couple an FTIR spectrometer to a Langmuir trough. This
approach yields internal reflection IR spectra of a supported
monolayer that was exposed to a bulk solvent phase in which
buffers, proteins, and other reagents could be introduced. Early
work was performed using the Langmuir–Blodgett [23,24]
technique to deposit a phospholipid A-type monolayer onto a
polished germanium crystal surface [22]. It quickly became
clear, however, that the physical state of the Langmuir
monolayer was not being faithfully transferred to the supported
monolayer [25]. Therefore, a Langmuir–Schaefer technique
was adopted in which the internal reflection crystal was applied
flat onto a monolayer (Fig. 1) [26,27]. This approach was
simpler, more reproducible, and allowed for use of a smaller
subphase volume than the Langmuir–Blodgett approach. It also
enabled the instrument to collect spectra from lipid bilayers
prepared by the fusion of lipid vesicles to the crystal surface
[28,29] as well as lipid monolayers prepared in a Langmuir
trough. In practice, monolayers are applied to a 50×10×2 mm
germanium crystal by slowly elevating the trough until the
monolayer contacts the crystal surface. Because the crystal does
not move and beam alignment is preserved throughout anopy. A silane-treated 52×10×2 mm germanium crystal is fixed in a horizontal
ay be directed into one of its 30° end-facets and collected from the other. In this
reflects 21 times on the upper surface and 22 times on the lower surface before
interface in a Langmuir trough. Membrane surface pressure is set and maintained
moving piston. The monolayer is applied to the crystal surface by elevating the
ntroduced into the continuously stirred subphase by needle injection through the
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interference fringing.
The most recent modification to the current instrument is the
use of a moving piston to control surface pressure by
depositing or withdrawing lipids from the monolayer surface
(Fig. 1). The use of a piston, and a Wilhemy wire method to
measure surface pressure [30], provides for a minimum
subphase volume. Internal reflection studies are typically
performed with 20 μg aliquots of protein injected into a
subphase volume of 3–4 ml. The subphase concentration of Aβ
proteins, therefore, is 1–2 μM, and amide I amplitudes range
from 0.001 to 0.020 AU. In contrast, roughly 80 μg of protein
concentrated in a volume of 20 μl (about 1 mM of Aβ protein)
is typically necessary to obtain a similar spectral amplitude
with transmission IR.
The surface of the crystal is prepared by physical polishing,
rigorous cleaning, and treatment with octadecyltrichlorosilane
before use to render the surface receptive to the hydrophobic
side of the lipid monolayer. Beveled facets at either end of the
crystal permit entry of an IR beam at an incidence angle of 30°
relative to the surface normal. The critical angle for internal
reflection is 19−22° depending on whether one is considering
the interface between the crystal and water, or the crystal and the
lipid monolayer. An enclosure around the Langmuir trough is
filled with argon to avoid spontaneous air oxidation of lipids
and spectral interference from water vapor.
Baseline spectra are collected after preparing a monolayer
and applying it to an internal reflection crystal. Samples are
injected into the subphase buffer and the spectra of monolayer-
adsorbed materials are then collected. The monolayer does not
contribute to the sample spectra when it is present in the
background spectra. In general, the concentrations of material in
the subphase are sufficiently low that absorption bands only
arise from material that has adsorbed to the monolayer. Both the
background and the sample spectra are collected with the
polarizer oriented parallel and perpendicular to the plane of
incidence. To avoid absorption bands that overlap with amide I,
the subphase consists of HEPES buffer in D2O.
2.2. Linked analysis
Spectra are fit by a FORTRAN program IRfit on a UNIX
workstation. This program was adapted from Efit written earlier
for global analysis of multiexponential fluorescence intensity
decay [31]. In the IRfit program, each spectrum is fit with one
straight and level baseline and one or more component bands.
Each component band is specified by four parameters:
frequency, amplitude, full width at half-maximum, and shape
(% Gaussian, remainder=Lorentzian); initial values for each
parameter must be selected. The parameter values are adjusted
by means of the downhill simplex method [32] to achieve
minimum least-squares residuals. Each spectrum was fit with
the minimum member of bands sufficient to meet three criteria:
(a) narrow uncorrelated residual amplitudes correspond in
magnitude to the apparent noise of the original spectra, and (c)
reduction of the χ2 gradient to within 1 order of magnitude of
single-precision arithmetic.There are two particularly valuable features of the IRfit
program. One, different users generally obtain similar results for
any given set of spectra. Two, multiple bands may be fit
simultaneously with parameters that are linked (i.e., shared, or
constrained to the same value). Thus, linked analysis reduces
the number of independent fitting parameters being applied to
the available data (increasing the ratio of data to fitting
parameters), and it increases the information content of each
parameter by overdetermining its value. As a consequence, the
likelihood of arriving at a unique fitting solution is greatly
enhanced (though not guaranteed), and the gradient at most
points in the χ2 surface will be steeper, yielding greater pre-
cision for individual parameters.
The aim of “linked analysis” is to exploit the reasonable
expectation that changing the polarization of a spectrum will
change the relative amplitudes of component bands but it should
not change their frequency, width, or shape. These parameters
should also remain unchanged in repetitions of the same
spectral measurement. Conversely, linked analysis is not an
attempt to resolve latent features of amide I spectra. Fourier self-
deconvolution [33] can be employed within IRfit to select initial
parameter values, but parameters are adjusted to fit the original
data, not a deconvolved spectrum. Nevertheless, simultaneous
linked analysis can detect and recover component bands that are
otherwise not resolvable [27]. This advantage is most likely to
be gained when components in the absorption spectra differ in
relative amplitudes, as to be expected when the polarization is
changed.
One concern raised about linked analysis is that it yields a
single-valued result for most parameters and no estimate for the
uncertainly in their value. This is true for the frequency, width,
and shape parameters in the work presented in this review.
However, there is no requirement for precision in these values.
Rather, the overriding requirement is for consistency in their
value between experiments so that meaningful comparisons
may be made. Linked analysis provides for this consistency, yet
while also providing independent component amplitude results
that may then be subjected to ordinary error analysis.
2.3. Dichroic ratios and order parameters
Dichroic ratios, Rz= ∫A///∫A⊥ are derived from the polarized
absorption spectra using integrated areas of characteristic
absorption bands, ∫A, as determined by the linked analysis,
IRfit. Dichroic ratios are converted to order parameters, S(Rz),
according to
S Rzð Þ ¼
hE2xi  RzhE2yi þ hE2z i
hE2xi  RzhE2yi  2hE2z i
where 〈Ex〉 〈Ey〉 and 〈Ez〉 are the mean electric field
amplitude components, x is the direction of beam propaga-
tion, y is oriented transverse to the beam propagation in the
plane of the membrane, and z is normal to the membrane.
Electric field amplitudes are calculated according to the so-
called two-phase or thick film approximation [34–36]. The
accuracy of various approximations for supported lipid
Fig. 2. PATIR-FTIR spectra of isotopically-labeled amino-acetylated hexapep-
tides (Ac-WLLLLL-COO−) in a lipid membrane. This hexapeptide is known to
aggregate and form amyloid-like β-structure in membranes [97]. A 13C label
was placed in the peptide group of Leu3 and spectra were collected of
membrane-bound aggregates formed by the labeled polypeptide, the unlabeled
polypeptide, and a 1:3 mixture of labeled:unlabeled polypeptide. The
juxtaposition of 13C labels in an antiparallel β sheet results in an anomalous
enhancement of absorption by the labeled peptide group at 1600 cm−1. Dilution
of the label with unlabeled polypeptide results in less enhancement, and a
smaller red shift relative to the absorption maximum of an unlabeled polypeptide
at 1626 cm−1.
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of the two-phase approximation for the experimental config-
uration described herein is supported by their accuracy with
reference standards [38,39]. An order parameter of 1.0
indicates a uniform orientation perpendicular to the membrane
surface, while a value of −0.5 indicates a uniform orientation
parallel to the membrane. An order parameter of 0.0 may
indicate either a uniform orientation at the magic angle (54.7°
relative to the surface normal), complete disorder as in an
isotropic system, or any other orientation distribution for
which γ is the “tilt” angle between the molecular axis and the
surface normal and 〈cos2γ〉=1/3.
2.4. Nomenclature
The shape and position of amide I absorption bands are
slightly altered in D2O by the H→D substitution, and are often
marked with a prime (as in amide I′) to indicate that this effect is
present. Literature in this field is subject to confusion because
different investigations are performed on different forms of the
Aβ protein. Herein, Aβ40 and Aβ42 designate 40- and 42-
residue Aβ proteins. Aβm−n designates a polypeptide segment
corresponding to residues m through n of Aβ42, and an
amidated C-terminus is designated by n′.
3. IR spectroscopy and amyloid structure
Early X-ray scattering studies indicated that fibrils possess
cross-β structure [40], [41] while infrared spectroscopy
detected a widely split amide I band suggesting that this β
structure is antiparallel [42,43]. The splitting observed in an
amide I spectrum of an unlabeled antiparallel β sheet arises
from intermode coupling [44], and the extent of the split
depends on the number of polypeptide strands in a sheet
[45]. The appearance of amide I splitting may be mimicked
by trifluoroacetate remaining in the sample after purification
[46], but this does not appear to be the case in Aβ fibrils.
Early work with isotope edited IR spectroscopy and Aβ34–42
supported the idea that fibrils had antiparallel β structure
[47], as did subsequent solid state NMR (SS-NMR) studies
of fibrils formed from Aβ34–42 [48], Aβ16–22′ [49], and
Aβ11–25 [50]. In light of all these data suggesting antiparallel
β structure, it was surprising when SS-NMR studies of
fibrils formed by Aβ10–35′ [51] and by full-length Aβ40
[52], [53] as well as EPR studies [54] indicated that these
longer segments both formed fibrils with parallel in-register
β structure.
Isotopic labeling of peptide bonds with 13C has multiple
interrelated effects on the amide I′ spectrum that have been the
subject of detailed theoretical analysis [55–58]. This approach
has been used to advantage in numerous infrared studies [59],
including that of a hexapeptide that forms amyloid-like
extended β-sheet structures in membranes [60]. These latter
studies clearly illustrated that labeled groups in regular β
structure exhibited an anomalous enhancement of absorption,
and that the frequency of this absorption band depended on
inter-label proximity (Fig. 2).The same approach was used in IR spectroscopy studies
of isotopically labeled Aβ10–35′ and Aβ40. Unlabeled
unaggregated Aβ40 yields a broad featureless amide I′
band maximal at 1658 cm−1 (Fig. 3); the same is true of
various 13C-labeled forms of Aβ40 as well as labeled and
unlabeled forms of Aβ10–35′ before they are aggregated.
After aggregation into fibrils, the amide I′ band of unlabeled
Aβ40 (and Aβ10–35′) is maximal at 1624 cm
−1 and has a
high frequency shoulder at 1685 cm−1. When residues F20,
A21, or A30 are labeled with 13C and allowed to aggregate,
low frequency shoulders with varying amplitudes and
frequencies are evident. The pattern of amplitudes and
frequency shifts is complex, but consistent with parallel in-
register β-sheet structure [61]. They also suggest that
structural differences exist between Aβ10–35′ and Aβ40 in
the vicinity of residue A30. Moreover, the presence of a
shoulder and a well-resolved peak in the spectrum of Aβ10–
35′-F20 suggests that two distinct structures are present. The
same conclusions are also suggested by the dual resonances
observed in NMR studies of correspondingly labeled Aβ40
[53], and the multiple resonances arising from labeling of the
adjacent residue (Ala21) in Aβ10–35′ [62].
4. Aβ42 and oxidatively damaged lipid membranes
PATIR-FTIR spectra of Aβ42 on monolayer membranes
made from 100% DMPC or oxidatively damaged SAPC (20
mol% SAPC, 80 mol% DMPC) are illustrated in Fig. 4 [63].
The oxidative damage was produced by a mixture of ascorbate
and cupric ions. Although hydroperoxides, conjugated dienes,
Fig. 3. Amide I' infrared spectra of Aβ10–35′ (top panel) and Aβ40 (bottom
panel) proteins. The vertical axes indicate relative absorbance, and a dashed line
is drawn at 1625 cm−1. All except the bottom spectrum represent aggregated
protein. UL—unlabeled. F20, A21, and A30—13C labels in C1 of phenylalanine
or alanine residues at positions 20, 21, and 30, respectively. A21/UL is one part
A21 protein mixed in organic phase with 3 parts UL protein before fibril
formation. A21/A30 is a 1:1 ratio of A21 and A30 proteins mixed in organic
phase before fibril formation.
1917H. Komatsu et al. / Biochimica et Biophysica Acta 1768 (2007) 1913–1922and isoprostanes were among the many products likely
produced, only a small fraction of the SAPC was actually
damaged by the treatment employed [64,65].
In both membranes, the most prominent spectral feature is a
component centered at∼1623 cm−1 that most likely arises from
membrane-adsorbed Aβ42 in a β-sheet conformation. The
broader and less conspicuous component at ∼1650 cm−1
suggests that some of the adsorbed protein has a helical or
random coil structure. The latter is of similar amplitude on both
membrane types. However, the amplitude of the 1623 cm−1
component is much larger on oxidatively damaged membranes.
amounts of GM1 (3 mol%) in a DMPC membrane caused the
same acceleration of Aβ42 accumulation as oxidative damage.
The relationship between GM1 and Aβ is reviewed by
Matsuzaki elsewhere in this issue.
Aβ42 is relatively hydrophobic, and will accumulate at an
air–water interface in the absence of a membrane. When thisprotein was applied to the internal reflection crystal, it had an
absorption maximum of 1648 cm−1 and very little signal
characteristic of β-sheet. This result demonstrated that Aβ42
did not adopt a β-sheet conformation in the subphase, and that it
was the presence of a membrane, especially an oxidized
damaged membrane, that induced Aβ42 to assume an
antiparallel β-structure.
Infrared extinction coefficients vary for different secondary
structures [66], therefore quantitative analyses were only
performed on individual component bands. The dichroic ratio
of∼1.0 for the 1623 cm−1 band is at the extreme low end of the
range of physically possible ratios, indicating that the transverse
mode of the β-sheet structure (the longitudinal axis of the fibril)
lies parallel to the membrane surface. Ratios of 1.19–1.27 for
the 1685 cm−1 component indicate that the longitudinal mode
of the β sheet (a transverse axis of the fibril) also tends to lie
horizontally on the membrane. This could occur either if the
fibril was not twisted, or if only short segments of a twisted
fibril were present.
In summary, these experiments point to the possibility of a
direct mechanistic link between oxidative stress and amyloid
fibril formation, mediated by oxidizable lipids in membranes.
Oxidative damage causes Aβ42 to form amyloid fibrils and
accumulate on a membrane with their long axis oriented parallel
to the membrane surface.
5. Aβ40 and oxidatively damaged lipid membranes
Aβ42 appears to be the predominate Aβ species in diffuse
immature plaques [67–70], whereas Aβ40 and various amino-
and carboxy-terminal derivatives appear to be the predominant
Aβ protein in the amyloid plaques of AD [71]. Therefore it has
been suggested that Aβ42 serves to nucleate amyloid plaque
formation [72–75].
The ability of Aβ42 to seed fibril formation by Aβ40 was
observed with PATIR-FTIR spectroscopy. However, this effect
was only observed on membranes containing oxidatively
damaged SAPC (Fig. 5) [76]. The interaction between Aβ40,
Aβ42, and oxidatively damaged lipids was also examined using
lipid vesicles and a Congo Red assay to detect fibril formation.
Again, it was observed that Aβ42 had a significantly enhanced
ability to promote fibril formation by Aβ40 in the presence of
oxidatively damaged SAPC lipid.
The experiments with vesicles and Congo Red were
performed primarily to verify that the PATIR-FTIR spectra
did indeed predict fibril formation. However, they also
illustrated three advantages of PATIR-FTIR spectroscopy for
studies of this type. First, PATIR-FTIR spectroscopy detected
the effect of oxidatively damaged SAPC on folding behavior in
minutes rather than the days required for the Congo Red.
Second, PATIR-FTIR spectroscopy obtained clear results from
300 nM solutions of each protein. In comparison, the dye
binding assay required 2.5 μM Aβ42 and 10 μM Aβ40. Third,
PATIR-FTIR spectroscopy provides additional information
about adsorption kinetics, secondary structure, and the
organizational state of membranes lipids. Fibril assays using
thioflavin T fluorescence [77] are more sensitive than Congo
Fig. 4. Amide I bands in the PATIR-FTIR spectra of Aβ42 peptide bound to monolayers composed of DMPC (a) and (b), and 20 mol% oxidized SAPC in DMPC, (c)
and (d). Parallel-polarized spectra are shown in (a) and (c); perpendicularly polarized spectra in (b) and (d). Experimental data represented by discrete symbols;
individual component bands obtained from IRfit are shown in thin lines, and the sum of the fit components is represented by a thick solid line overlying most of the data
points.
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a speed advantage, and they are susceptible to interference from
lipids.
6. Aβ proteins and pathological positive feedback
In all of the aforementioned experiments, oxidative damage
was produced by treating SAPC with ascorbate and cupric ion.
Ascorbate reduces Cu(II) to Cu(I), which in turn reduces
molecular oxygen to highly reactive species that oxidize the
polyunsaturated fatty acyl chains of lipids. Aβ proteins are
known to bind Cu(II) with high affinity, reduce it to Cu(I),
produce H2O2, and oxidize compounds such as dopamine,
cholesterol and ascorbate [78–85]. Therefore, it was of interest to
examine whether Aβ proteins accelerated lipid oxidative damage.Fig. 5. Amide I′ bands in the ATIR-FTIR spectra of Aβ proteins. data are represented
in thin lines, and the sum of the fit components is represented by a thick solid line o
injections of Aβ40 at time=0, 1, and 2 h, and 16 μg at 3 h on a membrane contain
time=4 h after an 8 μg injections of Aβ42 at time=0, 8 μg injections of Aβ40 at tim
absorption maximum is 0.0032.For this purpose, anMRM-ESI-LC/MS/MS assay was developed
that determined SAPC concentrations relative to DMPC. The
latter is not readily oxidized under the conditions of these
experiments, and therefore functions as an internal standard.
Fig. 6 shows that Aβ42 is a potent promoter of lipid
oxidation [65]. Mutations of Met35, His13, or His14 effectively
negated this prooxidant activity. Catalase had little effect, but
the antioxidant BHT, the copper chelator DTPA, and anaerobic
conditions also negated this activity. The Aβ42 that promoted
oxidative damage would not pass through a 10 kDa poly-
carbonate filter, and its IR spectrum resembled Aβ42-seeded
Aβ40 on an oxidatively damaged membrane (Fig. 5b) more so
than mature fibrils (Fig. 4).
The ability of oxidatively damaged lipids to promote
pathological β-structure in Aβ proteins, coupled with the abilityby discrete symbols; individual component bands obtained from IRfit are shown
verlying most of the data points. (a) Spectrum recorded at time=4 h after 8 μg
ing oxidized SAPC. absorption maximum is 0.0011. (b) Spectrum recorded at
e=1 and 2 h, and 16 μg at 3 h on a membrane containing oxidized SAPC. The
Fig. 6. The pro-oxidant activity of Aβ42. (a) Lipid determinations are expressed as the fraction of undamaged SAPC, and results were normalized to 1.0 at the
beginning of an experiment. Aβ42 caused nearly all of the SAPC to be oxidized, and catalase was ineffective at inhibiting the damage. All other conditions inhibited
most of the oxidative damage. (b) Amide I′ band in the ATIR-FTIR spectra of Aβ42 under these conditions.
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suggests that a positive feedback mechanism may be responsible
for producing amyloid fibrils (Fig. 7). Such a mechanism may be
initiated by an acute oxidative stress, an insufficiency of
antioxidant mechanisms in the brain, or Aβ overproduction due
to the mutations known to cause familial AD.
This mechanism may also explain the link between
apolipoprotein E isoforms and risk of developing AD. ApoE
is found in the senile amyloid plaques of AD brain, and there
appears to be no structural difference between lipoprotein
particles formed from the three predominant isoforms (a
conclusion reached, in large part, using PATIR-FTIR spectro-
scopy) [86]. However, the apoE2 isoform with a R158C
substitution is associated with a lower risk relative to wild type
apoE3, while the apoE4 isoform with a C112R substitution is
associated with a higher risk. Thus, risk is inversely related to
the number of Cys residues in apoE. The free thiols of Cys
residues have been shown to exert a significant antioxidant
activity in apoA-I [87]. Thus, carriers of the apoE4 allele may be
at higher risk of AD because of an inadequate antioxidant
mechanism in the principle apolipoprotein of the brain.
7. Positive feedback and the amyloid hypothesis
According to the “amyloid hypothesis”, the pathogenesis of
AD is driven by the accumulation of Aβ proteins [88]. This
hypothesis was initially based on genetic studies of familial AD
and the occurrence of AD-like pathology in Down's Syndrome.
A large amount of experimental evidence has accumulated in
the interim that supports the hypothesis [89–92]. Nevertheless,
it has been criticized as incomplete, vague, and unable to
explain non-familial or sporadic cases of AD, the most
prevalent form [93]. Moreover, it also does not explain the
occurrence or role of oxidative stress in the pathogenesis of AD.Fig. 7. A possible positive feedback mechanism in which oxidative lipid damage
and Aβ misfolding promote each other.The positive feedback mechanism we have outlined above
is one means by which oxidative stress may be linked to fibril
formation, with oxidative stress causing fibrils to form under
circumstances where they would otherwise not. However,
questions remain about whether Aβ fibrils or prefibrillar
intermediate forms of Aβ are the primary neuropathological
entity in AD. A primary role for nonfibrillar oligomeric species
has been suggested by experiments in which these forms
impair physiological and cognitive function when injected into
rat brain [94–96]. As the amyloid hypothesis matures and
evolves, attention must be focused on distinguishing which
form or forms of the Aβ protein are responsible for
neurotoxicity, identifying factors that lead to their appearance
in AD, and developing interventions that reduce their
formation.
8. Summary
Studies of the interaction between Aβ proteins and lipid
membranes with PATIR-FTIR spectroscopy have revealed that
these proteins have an accelerated tendency to form fibril-like β
structure on oxidatively damaged lipid membranes. The protein
is superficially adsorbed to the membrane surface, and the fibril
axis lies parallel to the membrane surface. This acceleration has
been observed with Aβ42, and with Aβ40 when an oxidatively
damaged membrane is seeded with Aβ42. The chemical nature
of the damage, and the oxidation products responsible for the
acceleration, have yet to be identified. Aβ proteins have also
been shown to accelerate oxidative lipid damage. Hence, a
positive feedback mechanism may exist in which oxidative
damage promotes the misfolding of Aβ proteins, and misfolded
Aβ proteins promote oxidative damage. This mechanism may
explain the chemical relationship between two conspicuous
features of AD pathology, namely oxidative stress and amyloid
fibril formation, and it is compatible with the known genetic
risk factors for developing AD.
Acknowledgements
Supported by grants from the National Institute of Aging, the
American Health Assistance Foundation, and the Alzheimer's
Association.
1920 H. Komatsu et al. / Biochimica et Biophysica Acta 1768 (2007) 1913–1922References
[1] C.L. Shen, R.M. Murphy, Solvent effects on self-assembly of beta-amyloid
peptide, Biophys. J. 69 (1995) 640–651.
[2] W.R. Markesbery, The role of oxidative stress in Alzheimer disease, Arch.
Neurol. 56 (1999) 1449–1452.
[3] D. Pratico, N. Delanty, Oxidative injury in diseases of the central nervous
system: focus on Alzheimer's disease, Am. J. Med. 109 (2000) 577–585.
[4] S. Varadarajan, S. Yatin, M. Aksenova, D.A. Butterfield, Review:
Alzheimer's amyloid beta-peptide-associated free radical oxidative stress
and neurotoxicity, J. Struct. Biol. 130 (2000) 184–208.
[5] A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K.
Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood,
R.B. Petersen, M.A Smith, Oxidative damage is the earliest event in
Alzheimer disease, J. Neuropathol. Exp. Neurol. 60 (2001) 759–767.
[6] S. Arlt, U. Beisiegel, A. Kontush, Lipid peroxidation in neurodegenera-
tion: new insights into Alzheimer's disease, Curr. Opin. Lipidol. 13 (2002)
289–294.
[7] D.A. Butterfield, Amyloid beta-peptide [1–42]-associated free radical-
induced oxidative stress and neurodegeneration in Alzheimer's disease
brain: mechanisms and consequences, Curr. Med. Chem. 10 (2003)
2651–2659.
[8] T.A. Bayer, S. Schafer, H. Breyhan, O. Wirths, C. Treiber, G. Multhaup, A
vicious circle: role of oxidative stress, intraneuronal A beta and Cu in
Alzheimer's disease, Clin. Neuropathol. 25 (2006) 163–171.
[9] E. Terzi, G. Holzemann, J. Seelig, Self-association of beta-amyloid peptide
(1–40) in solution and binding to lipid membranes, J. Mol. Biol. 252
(1995) 633–642.
[10] K. Yanagisawa, A. Odaka, N. Suzuki, Y. Ihara, GM1 ganglioside-bound
amyloid beta-protein (A beta): a possible form of preamyloid in
Alzheimer's disease, Nat. Med. 1 (1995) 1062–1066.
[11] E. Terzi, G. Holzemann, J. Seelig, Interaction of Alzheimer beta-amyloid
peptide(1–40) with lipid membranes, Biochemistry 36 (1997)
14845–14852.
[12] J. McLaurin, A. Chakrabartty, Characterization of the interactions of
Alzheimer beta-amyloid peptides with phospholipid membranes, Eur. J.
Biochem. 245 (1997) 355–363.
[13] L.-P. Choo-Smith, W. Garzon-Rodriguez, C.G. Glabe, W.K. Surewicz,
Acceleration of amyloid fibril formation by specific binding of Abeta-
(1–40) peptide to ganglioside-containing membrane vesicles, J. Biol.
Chem. 272 (1997) 22987–22990.
[14] L.-P. Choo-Smith, W.K. Surewicz, The interaction between Alzheimer
amyloid beta(1–40) peptide and ganglioside GM1-containing membranes,
FEBS Lett. 402 (1997) 95–98.
[15] J. McLaurin, T. Franklin, P.E. Fraser, A. Chakrabartty, Structural
transitions associated with the interaction of Alzheimer beta-amyloid
peptides with gangliosides, J. Biol. Chem. 273 (1998) 4506–4515.
[16] D.A. White, The Phospholipid Composition of Mammalian Tissue,
Elsevier, New York, 1973.
[17] C. Jeandel, M.B. Nicolas, F. Dubois, F. Nabet-Belleville, F. Penin, G.
Cuny, Lipid peroxidation and free radical scavengers in Alzheimer's
disease, Gerontology 35 (1989) 275–282.
[18] Q.H. Zhang, E.T. Powers, J. Nieva, M.E. Huff, M.A. Dendle, J. Bieschke,
C.G. Glabe, A. Eschenmoser, P. Wentworth, R.A. Lerner, J.W. Kelly,
Metabolite-initiated protein misfolding may trigger Alzheimer's disease,
Proc. Natl. Acad. Sci. U. S A. 101 (2004) 4752–4757.
[19] J. Bieschke, Q. Zhang, E.T. Powers, R.A. Lerner, J.W. Kelly, Oxidative
metabolites accelerate Alzheimer's amyloidogenesis by a two-step
mechanism, eliminating the requirement for nucleation, Biochemistry 44
(2005) 4977–4983.
[20] D. Marsh, Dichroic ratios in polarized Fourier transform infrared for
nonaxial symmetry of beta-sheet structures, Biophys. J. 72 (1997)
2710–2718.
[21] P.H. Axelsen, B.K. Kaufman, R.N. McElhaney, R.N.A.H. Lewis, The
infrared dichroism of transmembrane helical polypeptides, Biophys. J. 69
(1995) 2770–2781.
[22] P.H. Axelsen, W.D. Braddock, H.L. Brockman, C.M. Jones, R.A. Dluhy,
B.K. Kaufman, F.J. Puga Jr., Use of internal reflectance infraredspectroscopy for the in-situ study of supported lipid monolayers, Appl.
Spectrosc. 49 (1995) 526–531.
[23] K.B. Blodgett, Monomolecular films of fatty acids on glass, J. Am. Chem.
Soc. 56 (1934) 495.
[24] K.B. Blodgett, Films built by depositing successive monomolecular layers
on a solid surface, J. Am. Chem. Soc. 57 (1935) 1007–1022.
[25] F.R. Rana, S. Widayati, B.W. Gregory, R.A. Dluhy, Metasability in
monolayer films transferred onto solid substrates by the Langmuir–
Blodgett method: IR evidence for the transfer-induced phase transitions,
Appl. Spectrosc. 48 (1994) 1196–1203.
[26] I. Langmuir, V.J. Schaefer, Activities of urease and pepsin monolayers,
J. Am. Chem. Soc. 60 (1938) 1351–1360.
[27] L. Silvestro, P.H. Axelsen, FTIR linked analysis of conformational
changes in Annexin V upon membrane binding, Biochemistry 38 (1999)
113–121.
[28] E. Kalb, S. Frey, L.K. Tamm, Formation of supported planar bilayers by
fusion of vesicles to supported phospholipid monolayers, Biochim.
Biophys. Acta 1103 (1992) 307–316.
[29] L. Silvestro, P.H. Axelsen, Infrared spectroscopy of supported lipid
monolayer, bilayer, and multibilayer membranes, Chem. Phys. Lipids 96
(1998) 69–80.
[30] W.E. Momsen, J.M. Smaby, H.L. Brockman, The suitability of nichrome
for measurement of gas–liquid interfacial tension by the Wilhelmy
method, J. Colloid Interface Sci. 135 (1990) 547–552.
[31] P.H. Axelsen, Z. Bajzer, F.G. Prendergast, P.F. Cottam, C. Ho,
Resolution of fluorescence intensity decays of the two tryptophan
residues in glutamine-binding protein of E. coli using single tryptophan
mutants, Biophys. J. 60 (1991) 650–659.
[32] W.H. Press, B.P. Flannery, S.A. Teukolsky, W.T. Vetterling, Numerical
Recipes, Cambridge Univ. Press, Cambrige, 1986.
[33] J.K. Kauppinen, D.J. Moffatt, M.R. Hollberg, H.H. Mantsch, A new line-
narrowing procedure based on Fourier self-deconvolution, maximum
entropy, and linear prediction, Appl. Spectrosc. 45 (1991) 411–416.
[34] N.J. Harrick, Internal Reflection Spectroscopy, Harrick Scientific
Corporation, Ossining, NY, 1967.
[35] F.J. Mirabella, N.J. Harrick, Internal Reflection Spectroscopy: Review and
Supplement, N.J. Harrick, Harrick Scientific Corporation, Ossining, N.Y.,
1985.
[36] F.J. Mirabella, Internal Reflection Spectroscopy: Theory and Applications,
F.J. Mirabella, Dekker, New York, 1993.
[37] P.H. Axelsen, M.J. Citra, Orientational order determination by internal
reflection infrared spectroscopy, Prog. Biophys. Mol. Biol. 66 (1996)
227–253.
[38] M.J. Citra, P.H. Axelsen, Determination of molecular order in supported
lipid membranes by internal reflection Fourier transform infrared spectro-
scopy, Biophys. J. 71 (1996) 1796–1805.
[39] V. Koppaka, P.H. Axelsen, Evanescent electric field amplitudes in thin
lipid films for internal reflection infrared spectroscopy, Langmuir 17
(2001) 6309–6316.
[40] E.D. Eanes, G.G. Glenner, X-ray diffraction studies on amyloid filaments,
J. Histochem. Cytochem. 16 (1968) 673–677.
[41] D.A. Kirschner, C. Abraham, D.J. Selkoe, X-ray diffraction from
intraneuronal paired helical filaments and extraneuronal amyloid fibers
in Alzheimer's disease indicates cross-beta conformation, Proc. Natl.
Acad. Sci. U. S. A. 83 (1986) 503–507.
[42] C. Hilbich, B. Kisterwoike, J. Reed, C.L. Masters, K. Beyreuther,
Aggregation and secondary structure of synthetic amyloid beta-A4
peptides Of Alzheimer's-disease, J. Mol. Biol. 218 (1991) 149–163.
[43] H. Fabian, L. Choo, G.I. Szendrei, M. Jackson, W.C. Halliday, L. Otvos Jr.,
H.H Mantsch, Infrared spectroscopic characterization of Alzheimer
plaques, Appl. Spectrosc. 47 (1993) 1513–1518.
[44] S. Krimm, Y. Abe, Intermolecular interaction effects in the Amide I
vibrations of β polypeptides, Proc. Natl. Acad. Sci. U. S. A. 69 (1972)
2788–2792.
[45] Y.N. Chirgadze, N.A. Nevskaya, Infrared spectra and resonance interaction
of Amide-I vibration of the antiparallel-chain pleated sheet, Biopolymers
15 (1976) 607–625.
[46] W.K. Surewicz, H.H. Mantsch, The conformation of dynorphin A-(1–13)
1921H. Komatsu et al. / Biochimica et Biophysica Acta 1768 (2007) 1913–1922in aqueous solution as studied by Fourier transform infrared spectroscopy,
J. Mol. Struct. 214 (1989) 143–147.
[47] K.J. Halverson, I. Sucholeiki, T.T. Ashburn, P.T. Lansbury, Location of β-
Sheet-forming sequences in amyloid proteins by FTIR, J. Am. Chem. Soc.
113 (1991) 6701–6703.
[48] P.T. Lansbury, P.R. Costa, J.M. Griffiths, E.J. Simon, M. Auger, K.J.
Halverson, D.A. Kocisko, Z.S. Hendsch, T.T. Ashburn, R.G.S. Spencer, B.
Tidor, R.G. Griffin, Structural model for the beta-amyloid fibril based on
interstrand alignment of an antiparallel-sheet comprising a C-terminal
peptide, Nat. Struct. Biol. 2 (1995) 990–998.
[49] J.J. Balbach, Y. Ishii, O.N. Antzutkin, R.D. Leapman, N.W. Rizzo, F.
Dyda, J. Reed, R. Tycko, Amyloid fibril formation by A beta(16–22), a
seven-residue fragment of the Alzheimer's beta-amyloid peptide, and
structural characterization by solid state NMR, Biochemistry 39 (2000)
13748–13759.
[50] A.T. Petkova, G. Buntkowsky, F. Dyda, R.D. Leapman, W.-M. Yau, R.
Tycko, Solid state NMR reveals a pH-dependent antiparallel β-Sheet
registry in fibrils formed by a β-amyloid peptide, J. Mol. Biol. 335 (2004)
247–260.
[51] T.L.S. Benzinger, D.M. Gregory, T.S. Burkoth, H. Miller-Auer, D.G. Lynn,
R.E. Botto, S.C. Meredith, Propagating structure of Alzheimer's beta-
amyloid(10–35) is parallel beta-sheet with residues in exact register, Proc.
Natl. Acad. Sci. U. S. A. 95 (1998) 13407–13412.
[52] O.N. Antzutkin, J.J. Balbach, R.D. Leapman, N.W. Rizzo, J. Reed, R.
Tycko, Multiple quantum solid-state NMR indicates a parallel, not
antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid
fibrils, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13045–13050.
[53] J.J. Balbach, A.T. Petkova, N.A. Oyler, O.N. Antzutkin, D.J. Gordon, S.C.
Meredith, R. Tycko, Supramolecular structure in full-length Alzheimer's
beta-amyloid fibrils: evidence for a parallel beta-sheet organization from
solid-state nuclear magnetic resonance, Biophys. J. 83 (2002) 1205–1216.
[54] M. Torok, S. Milton, R. Kayed, P. Wu, T. McIntire, C.G. Glabe, R. Langen,
Structural and dynamic features of Alzheimer's A beta peptide in amyloid
fibrils studied by site-directed spin labeling, J. Biol. Chem. 277 (2002)
40810–40815.
[55] R.A.G.D. Silva, J. Kubelka, P. Bour, S.M. Decatur, T.A. Keiderling, Site-
specific conformational determination in thermal unfolding studies of
helical peptides using vibrational circular dichroism with isotopic
substitution, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8318–8323.
[56] J.W. Brauner, C. Dugan, R. Mendelsohn, C-13 isotope labeling of
hydrophobic peptides. Origin of the anomalous intensity distribution in the
infrared amide I spectral region of beta-sheet structures, J. Am. Chem. Soc.
112 (2000) 677–683.
[57] J. Kubelka, T.A. Keiderling, The anomalous infrared amide I intensity
distribution in C-13 isotopically labeled peptide beta-sheets comes from
extended, multiple-stranded structures. An ab initio study, J. Am. Chem.
Soc. 123 (2001) 6142–6150.
[58] J. Kubelka, T.A. Keiderling, Differentiation of beta-sheet-forming
structures: Ab initio-based simulations of IR absorption and vibrational
CD for model peptide and protein beta-sheets, J. Am. Chem. Soc. 123
(2001) 12048–12058.
[59] S.M. Decatur, Elucidation of residue-level structure and dynamics of
polypeptides via isotope-edited infrared spectroscopy, Acc. Chem. Res. 39
(2006) 169–175.
[60] C. Paul, J.P. Wang, W.C. Wimley, R.M. Hochstrasser, P.H. Axelsen,
Vibrational coupling, isotopic editing, and beta-sheet structure in a
membrane-bound polypeptide, J. Am. Chem. Soc. 126 (2004)
5843–5850.
[61] C. Paul, P.H. Axelsen, β sheet structure in amyloid β fibrils and vibrational
dipolar coupling, J. Am. Chem. Soc. 127 (2005) 5754–5755.
[62] O.N. Antzutkin, R.D. Leapman, J.J. Balbach, R. Tycko, Supramolecular
structural constraints on Alzheimer's beta-amyloid fibrils from electron
microscopy and solid-state nuclear magnetic resonance, Biochemistry 41
(2002) 15436–15450.
[63] V. Koppaka, P.H. Axelsen, Accelerated accumulation of amyloid beta
proteins on oxidatively damaged lipid membranes, Biochemistry 39 (2000)
10011–10016.
[64] E.A. Weinstein, H.W. Li, J.A. Lawson, J. Rokach, G.A. FitzGerald, P.H.Axelsen, Prothrombinase acceleration by oxidatively damaged phospho-
lipids, J. Biol. Chem. 275 (2000) 22925–22930.
[65] I.V.J. Murray, M.E. Sindoni, P.H. Axelsen, Promotion of oxidative lipid
membrane damage by amyloid beta proteins, Biochemistry 44 (2005)
12606–12613.
[66] H.H. de Jongh, E. Goormaghtigh, J.M. Ruysschaert, The different molar
absorptivities of the secondary structure types in the amide I region: an
attenuated total reflection infrared study on globular proteins, Anal.
Biochem. 242 (1996) 95–103.
[67] D.L. Miller, I.A. Papayannopoulos, J. Styles, S.A. Bobin, Y.Y. Lin, K.
Biemann, K. Iqbal, Peptide compositions of the cerebrovascular and senile
plaque core amyloid deposits of Alzheimer's disease, Arch. Biochem.
Biophys. 301 (1993) 41–52.
[68] D.J. Selkoe, Alzheimer's amyloid of another flavour, Nat. Med. 1 (1995)
998–999.
[69] T. Iwatsubo, T.C. Saido, D.M. Mann, V.M.Y. Lee, J.Q. Trojanowski, Full-
length amyloid-beta (1–42(43)) and amino-terminally modified and
truncated amyloid-beta 42(43) deposit in diffuse plaques, Am. J. Pathol.
149 (1996) 1823–1830.
[70] A. Kakio, S.I. Nishimoto, Y. Kozutsumi, K. Matsuzaki, Formation of a
membrane-active form of amyloid beta-protein in raft-like model
membranes, Biochem. Biophys. Res. Commun. 303 (2003) 514–518.
[71] H. Mori, K. Takio, M. Ogawara, D.J. Selkoe, Mass spectrometry of
purified amyloid beta protein in Alzheimer's disease, J. Biol. Chem. 267
(1992) 17082–17086.
[72] J.T. Jarrett, E.P. Berger, P.T. Lansbury, The carboxy terminus of the beta
amyloid protein is critical for the seeding of amyloid formation:
implications for the pathogenesis of Alzheimer's disease, Biochemistry
32 (1993) 4693–4697.
[73] J.T. Jarrett, P.T. Lansbury, Seeding “one-dimensional crystallization” of
amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell
73 (1993) 1055–1058.
[74] J.D. Harper, P.T. Lansbury, Models of amyloid seeding in Alzheimer's
disease and scrapie: mechanistic truths and physiological consequences of
the time-dependent solubility of amyloid proteins, Annu. Rev. Biochem.
66 (1997) 385–407.
[75] M. Pitschke, R. Prior, M. Haupt, D. Riesner, Detection of single
amyloid beta-protein aggregates in the cerebrospinal fluid of Alzhei-
mer's patients by fluorescence correlation spectroscopy, Nat. Med. 4
(1998) 832–834.
[76] V. Koppaka, C. Paul, I.V.J. Murray, P.H. Axelsen, Early synergy between
Aβ42 and oxidatively damaged membranes in promoting amyloid fibril
formation by Aβ40, J. Biol. Chem. 278 (2003) 36277–36284.
[77] H. Naiki, K. Higuchi, M. Hosokawa, T. Takeda, Fluorometric-determina-
tion of amyloid fibrils in vitro using the fluorescent dye, Thioflavine-T,
Anal. Biochem. 177 (1989) 244–249.
[78] X.D. Huang, M.P. Cuajungco, C.S. Atwood, M.A. Hartshorn, J.D.A.
Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E.
Goldstein, R.C. Scarpa, A.J. Saunders, J. Lim, R.D. Moir, C. Glabe, E.F.
Bowden, C.L. Masters, D.P. Fairlie, R.E. Tanzi, A.I. Bush, Cu(II)
potentiation of Alzheimer A beta neurotoxicity—Correlation with cell-
free hydrogen peroxide production and metal reduction, J. Biol. Chem. 274
(1999) 37111–37116.
[79] X.D. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein,
R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi,
A.I. Bush, The A beta peptide of Alzheimer's disease directly produces
hydrogen peroxide through metal ion reduction, Biochemistry 38 (1999)
7609–7616.
[80] C. Opazo, X.D. Huang, R.A. Cherny, R.D. Moir, A.E. Roher, A.R. White,
R. Cappai, C.L. Masters, R.E. Tanzi, N.C. Inestrosa, A.I. Bush,
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid—Cu-
dependent catalytic conversion of dopamine, cholesterol, and biological
reducing agents to neurotoxic H2O2, J. Biol. Chem. 277 (2002)
40302–40308.
[81] T.J. Nelson, D.L. Alkon, Oxidation of cholesterol by amyloid precursor
protein and beta-amyloid peptide, J. Biol. Chem. 280 (2005) 7377–7387.
[82] K.J. Barnham, F. Haeffner, G.D. Ciccotosto, C.C. Curtain, D. Tew,
K. Beyreuther, D. Carrington, C.L. Masters, R.A. Cherny, R. Cappai,
1922 H. Komatsu et al. / Biochimica et Biophysica Acta 1768 (2007) 1913–1922A.I. Bush, Tyrosine gated electron transfer is key to the toxic
mechanism of Alzheimer's disease β-amyloid, FASEB J. 18 (2004)
1427–1429.
[83] D.A. Butterfield, J. Kanski, Methionine residue 35 is critical for the
oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-
peptide 1–42 [Review], Peptides 23 (2002) 1299–1309.
[84] D.A. Butterfield, Amyloid beta-peptide (1–42)-induced oxidative stress
and neurotoxicity: Implications for neurodegeneration in Alzheimer's
disease brain. A review, Free Radical Res. 36 (2002) 1307–1313.
[85] D.A. Butterfield, A.I. Bush, Alzheimer's amyloid beta-peptide (1–42):
involvement of methionine residue 35 in the oxidative stress and
neurotoxicity properties of this peptide, Neurobiol. Aging 25 (2004)
563–568.
[86] L.A. Schneeweis, V. Koppaka, S. Lund-Katz, M.C. Phillips, P.H. Axelsen,
Structural analysis of lipoprotein E particles, Biochemistry 44 (2005)
12525–12534.
[87] J.K. Bielicki, M.N. Oda, Apolipoprotein A-I-Milano and apolipoprotein
A-I-Paris exhibit an antioxidant activity distinct from that of wild-type
apolipoprotein A-I, Biochemistry 41 (2002) 2089–2096.
[88] J. Hardy, D.J. Selkoe, Medicine—The amyloid hypothesis of Alzheimer's
disease: Progress and problems on the road to therapeutics, Science 297
(2002) 353–356.
[89] L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T.
Beach, J.H. Kurth, R.E. Rydel, J. Rogers, Soluble amyloid beta peptide
concentration as a predictor of synaptic change in Alzheimer's disease,
Am. J. Pathol. 155 (1999) 853–862.[90] C.A. Mclean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K.
Beyreuther, A.I. Bush, C.L. Masters, Soluble pool of A beta amyloid as a
determinant of severity of neurodegeneration in Alzheimer's disease, Ann.
Neurol. 46 (1999) 860–866.
[91] J. Wang, D.W. Dickson, J.Q. Trojanowski, V.M.Y. Lee, The levels of
soluble versus insoluble brain A beta distinguish Alzheimer's disease from
normal and pathologic aging, Exp. Neurol. 158 (1999) 328–337.
[92] J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard,
J.D. Buxbaum, Correlation between elevated levels of amyloid beta-
peptide in the brain and cognitive decline, JAMA-J. Am. Med. Assoc. 283
(2000) 1571–1577.
[93] A. Mandavilli, The amyloid code, Nat. Med. 12 (2006) 747–751.
[94] D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S.
Wolfe, M.J. Rowan, D.J. Selkoe, Naturally secreted oligomers of amyloid
beta protein potently inhibit hippocampal long-term potentiation in vivo,
Nature 416 (2002) 535–539.
[95] J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A.
Kuskowski, D.J. Selkoe, K.H. Ashe, Natural oligomers of the
amyloid-protein specifically disrupt cognitive function, Nat. Neurosci.
8 (2005) 79–84.
[96] S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M.
Gallagher, K.H. Ashe, A specific amyloid-beta protein assembly in the
brain impairs memory, Nature 440 (2006) 352–357.
[97] W.C. Wimley, K. Hristova, A.S. Ladokhin, L. Silvestro, P.H. Axelsen, S.H.
White, Folding of beta-sheet membrane proteins: a hydrophobic hexapep-
tide model, J. Mol. Biol. 277 (1998) 1091–1110.
